285 related articles for article (PubMed ID: 18618015)
1. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa.
Huard B; McKee T; Bosshard C; Durual S; Matthes T; Myit S; Donze O; Frossard C; Chizzolini C; Favre C; Zubler R; Guyot JP; Schneider P; Roosnek E
J Clin Invest; 2008 Aug; 118(8):2887-95. PubMed ID: 18618015
[TBL] [Abstract][Full Text] [Related]
2. Polarized Secretion of APRIL by the Tonsil Epithelium Upon Toll-Like Receptor Stimulation.
Sturm N; Quinterot M; Guyot JP; Righini C; Daamen WF; van Kuppevelt TH; Huard B
Front Immunol; 2021; 12():715724. PubMed ID: 34484218
[TBL] [Abstract][Full Text] [Related]
3. Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival.
Reijmers RM; Groen RW; Kuil A; Weijer K; Kimberley FC; Medema JP; van Kuppevelt TH; Li JP; Spaargaren M; Pals ST
Blood; 2011 Jun; 117(23):6162-71. PubMed ID: 21471524
[TBL] [Abstract][Full Text] [Related]
4. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
[TBL] [Abstract][Full Text] [Related]
5. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.
Tsiantoulas D; Eslami M; Obermayer G; Clement M; Smeets D; Mayer FJ; Kiss MG; Enders L; Weißer J; Göderle L; Lambert J; Frommlet F; Mueller A; Hendrikx T; Ozsvar-Kozma M; Porsch F; Willen L; Afonyushkin T; Murphy JE; Fogelstrand P; Donzé O; Pasterkamp G; Hoke M; Kubicek S; Jørgensen HF; Danchin N; Simon T; Scharnagl H; März W; Borén J; Hess H; Mallat Z; Schneider P; Binder CJ
Nature; 2021 Sep; 597(7874):92-96. PubMed ID: 34433968
[TBL] [Abstract][Full Text] [Related]
6. A proliferation-inducing ligand (APRIL): the development of antagonistic agents as potential therapeutics and deciphering the role of heparan sulphate proteoglycans (HSPGs) in APRIL Signalling.
Kimberley F; Guadagnoli M; van Eenennaam H; Medema JP
Adv Exp Med Biol; 2011; 691():501-6. PubMed ID: 21153355
[No Abstract] [Full Text] [Related]
7. The source of APRIL up-regulation in human solid tumor lesions.
Mhawech-Fauceglia P; Kaya G; Sauter G; McKee T; Donze O; Schwaller J; Huard B
J Leukoc Biol; 2006 Oct; 80(4):697-704. PubMed ID: 16793914
[TBL] [Abstract][Full Text] [Related]
8. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.
Belnoue E; Pihlgren M; McGaha TL; Tougne C; Rochat AF; Bossen C; Schneider P; Huard B; Lambert PH; Siegrist CA
Blood; 2008 Mar; 111(5):2755-64. PubMed ID: 18180376
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of APRIL by auto-induction.
Yu S; Wang Y; Liu Y; Mo W; Song H; Yu M
Protein Expr Purif; 2009 Nov; 68(1):49-53. PubMed ID: 19545632
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness.
Schwaller J; Schneider P; Mhawech-Fauceglia P; McKee T; Myit S; Matthes T; Tschopp J; Donze O; Le Gal FA; Huard B
Blood; 2007 Jan; 109(1):331-8. PubMed ID: 17190854
[TBL] [Abstract][Full Text] [Related]
11. Eosinophils: important players in humoral immunity.
Berek C
Clin Exp Immunol; 2016 Jan; 183(1):57-64. PubMed ID: 26291602
[TBL] [Abstract][Full Text] [Related]
12. Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway.
Ding W; Ju S; Jiang S; Zhu L; Wang Y; Wang H
Pathol Oncol Res; 2009 Dec; 15(4):693-701. PubMed ID: 19466596
[TBL] [Abstract][Full Text] [Related]
13. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells.
Tezuka H; Abe Y; Iwata M; Takeuchi H; Ishikawa H; Matsushita M; Shiohara T; Akira S; Ohteki T
Nature; 2007 Aug; 448(7156):929-33. PubMed ID: 17713535
[TBL] [Abstract][Full Text] [Related]
14. Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions.
Lombardi T; Moll S; Youinou P; Pers JO; Tzankov A; Gabay C; Santiago-Raber ML; Chizzolini C; Huard B
Rheumatology (Oxford); 2011 Jul; 50(7):1211-5. PubMed ID: 21325391
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils are required for the maintenance of plasma cells in the bone marrow.
Chu VT; Fröhlich A; Steinhauser G; Scheel T; Roch T; Fillatreau S; Lee JJ; Löhning M; Berek C
Nat Immunol; 2011 Feb; 12(2):151-9. PubMed ID: 21217761
[TBL] [Abstract][Full Text] [Related]
16. Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow.
Matthes T; Dunand-Sauthier I; Santiago-Raber ML; Krause KH; Donze O; Passweg J; McKee T; Huard B
Blood; 2011 Aug; 118(7):1838-44. PubMed ID: 21642598
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.
Hendriks J; Planelles L; de Jong-Odding J; Hardenberg G; Pals ST; Hahne M; Spaargaren M; Medema JP
Cell Death Differ; 2005 Jun; 12(6):637-48. PubMed ID: 15846369
[TBL] [Abstract][Full Text] [Related]
18. Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.
Matthes T; McKee T; Dunand-Sauthier I; Manfroi B; Park S; Passweg J; Huard B
Leukemia; 2015 Sep; 29(9):1901-8. PubMed ID: 25753925
[TBL] [Abstract][Full Text] [Related]
19. Re-thinking the functions of IgA(+) plasma cells.
Gommerman JL; Rojas OL; Fritz JH
Gut Microbes; 2014; 5(5):652-62. PubMed ID: 25483334
[TBL] [Abstract][Full Text] [Related]
20. CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.
Manfroi B; McKee T; Mayol JF; Tabruyn S; Moret S; Villiers C; Righini C; Dyer M; Callanan M; Schneider P; Tzankov A; Matthes T; Sturm N; Huard B
Cancer Res; 2017 Mar; 77(5):1097-1107. PubMed ID: 27923834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
